Role of the conserved threonine 309 in mechanism of oxidation by cytochrome P450 2D6

被引:30
作者
Keizers, PHJ
Schraven, LHM
de Graaf, C
Hidestrand, M
Ingelman-Sundberg, M
van Dijk, BR
Vermeulen, NPE
Commandeur, JNM
机构
[1] Free Univ Amsterdam, Div Mol Toxicol, Dept Pharmacochem, Ctr Drug Res, NL-1081 HV Amsterdam, Netherlands
[2] Karolinska Inst, Inst Environm Med, Div Mol Toxicol, S-17177 Stockholm, Sweden
关键词
cytochrome p450 2D6; T309V mutant; T312V mutant; product ratio; allosteric effects; reactive oxygen species;
D O I
10.1016/j.bbrc.2005.10.066
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Based on sequence alignments and homology modeling, threonine 309 in cytochrome P450 2D6 (CYP2D6) is proposed to be the conserved I-helix threonine, which is supposed to be involved in dioxygen activation by CYPs. The T309V mutant of CYP2D6 displayed a strong shift from O-dealkylation to N-dealkylation reactions in oxidation of dextromethorphan and 3,4-methylenedioxymethylamphet-amine. This may be explained by an elevated ratio of hydroperoxo-iron to oxenoid-iron of the oxygenating species. In consistence, using cumene hydroperoxide, which directly forms the oxenoid-iron, the T309V mutant again selectively catalyzed the O-dealkylation reactions. The changed ratio of oxygenating species can also explain the decreased activity and changed regioselectivity that were observed in 7-methoxy-4-(aminomethyl)-coumarin and bufuralol oxidation, respectively, by the T309V mutant. Interestingly, the T309V mutant always showed a significantly increased, up to 75-fold, higher activity compared to that of the wild-type when using cumene hydroperoxide. These results indicate that T309 in CYP2D6 is involved in maintaining the balance of multiple oxygenating species and thus influences substrate and regioselectivity. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:1065 / 1074
页数:10
相关论文
共 56 条
[1]   Formation of a novel reversible cytochrome P450 spectral intermediate: Role of threonine 303 in P450 2E1 inactivation [J].
Blobaum, AL ;
Lu, YP ;
Kent, UM ;
Wang, SM ;
Hollenberg, PF .
BIOCHEMISTRY, 2004, 43 (38) :11942-11952
[2]   CENTRALLY ACTIVE N-SUBSTITUTED ANALOGS OF 3,4-METHYLENEDIOXYPHENYLISOPROPYLAMINE (3,4-METHYLENEDIOXYAMPHETAMINE) [J].
BRAUN, U ;
SHULGIN, AT ;
BRAUN, G .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1980, 69 (02) :192-195
[3]   Hydroxylation by the hydroperoxy-iron species in cytochrome P450 enzymes [J].
Chandrasena, REP ;
Vatsis, KP ;
Coon, MJ ;
Hollenberg, PF ;
Newcomb, M .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2004, 126 (01) :115-126
[4]  
Coon MJ, 1998, DRUG METAB DISPOS, V26, P1190
[5]   Cytochrome P450: Nature's most versatile biological catalyst [J].
Coon, MJ .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2005, 45 :1-25
[6]   Substrate-assisted catalysis in cytochrome P450eryF [J].
CuppVickery, JR ;
Han, O ;
Hutchinson, CR ;
Poulos, TL .
NATURE STRUCTURAL BIOLOGY, 1996, 3 (07) :632-637
[7]   Novel approach to predicting P450-mediated drug metabolism: Development of a combined protein and pharmacophore model for CYP2D6 [J].
de Groot, MJ ;
Ackland, MJ ;
Horne, VA ;
Alex, AA ;
Jones, BC .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (09) :1515-1524
[8]   A proton-shuttle mechanism mediated by the porphyrin in benzene hydroxylation by cytochrome P450 enzymes [J].
de Visser, SP ;
Shaik, S .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2003, 125 (24) :7413-7424
[9]   METABOLITE PREDICTIONS FOR PARASUBSTITUTED ANISOLES BASED ON AB-INITIO COMPLETE ACTIVE SPACE SELF-CONSISTENT-FIELD CALCULATIONS [J].
DEGROOT, MJ ;
DENKELDER, GMDO ;
COMMANDEUR, JNM ;
VANLENTHE, JH ;
VERMEULEN, NPE .
CHEMICAL RESEARCH IN TOXICOLOGY, 1995, 8 (03) :437-443
[10]  
DEMONTELLANO PRO, 2005, CYTOCHROMES P450 STR